doxifluridine has been researched along with Disease Exacerbation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Araya, M; Fujiwara, H; Irinoda, T; Nakaya, T; Oyama, K; Saito, K; Takagane, A; Takahashi, M; Terashima, M; Yonezawa, H | 1 |
| Ding, W; Luo, B; Ma, ZM; Sheng, JM; Teng, LS; Wang, M; Wang, SF; Wu, FS; Zhao, WH | 1 |
| Honda, J; Kai, N; Kikuchi, K; Kikukawa, H; Kuwahara, T; Matsumoto, K; Nakanishi, J; Takahashi, W; Ueda, S; Wada, Y | 1 |
| Amano, M; Haba, A; Ikeda, K; Izawa, H; Kanoh, T; Monden, M; Monden, T; Ohnishi, T; Okamura, J; Sekimoro, M; Tomita, N; Tsujie, M | 1 |
| Artale, S; Bajetta, E; Bozzetti, F; Buzzoni, R; Di Bartolomeo, M; Mazzaferro, V; Ricci, SB; Stani, SC; Toffolatti, L | 1 |
| Mai, M; Nishioka, K; Taguchi, T; Takahashi, Y; Urushizaki, I | 1 |
1 review(s) available for doxifluridine and Disease Exacerbation
| Article | Year |
|---|---|
[PyNPase expression and cancer progression in the colorectum].
Topics: Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; Colorectal Neoplasms; Disease Progression; Floxuridine; Humans; Macrophages; Pentosyltransferases; Prognosis; Pyrimidine Phosphorylases | 1998 |
2 trial(s) available for doxifluridine and Disease Exacerbation
| Article | Year |
|---|---|
Apoptosis induced by preoperative oral 5'-DFUR administration in gastric adenocarcinoma and its mechanism of action.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Cell Proliferation; Disease Progression; Fas Ligand Protein; Female; Floxuridine; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Membrane Glycoproteins; Middle Aged; Prognosis; Proliferating Cell Nuclear Antigen; Stomach Neoplasms; Thymidine Phosphorylase; Tumor Necrosis Factors | 2006 |
Docetaxel, low-dose estramustine, and doxifluridine in hormone-refractory metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; Estramustine; Floxuridine; Granulocyte Colony-Stimulating Factor; Humans; Japan; Male; Middle Aged; Neutropenia; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Survival Rate; Taxoids | 2008 |
3 other study(ies) available for doxifluridine and Disease Exacerbation
| Article | Year |
|---|---|
Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Dihydrouracil Dehydrogenase (NADP); Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Floxuridine; Humans; Male; Middle Aged; Oxidoreductases; Stomach Neoplasms; Survival Analysis; Thymidine Phosphorylase | 2002 |
Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study.
Topics: Adult; Aged; Antidotes; Antineoplastic Agents; Combined Modality Therapy; Disease Progression; Feasibility Studies; Female; Floxuridine; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Pancreatectomy; Pancreatic Neoplasms; Survival Rate | 1999 |
Prolonged stable disease effects survival in patients with solid gastric tumor: analysis of phase II studies of doxifluridine.
Topics: Antimetabolites, Antineoplastic; Clinical Trials, Phase II as Topic; Disease Progression; Floxuridine; Humans; Multicenter Studies as Topic; Stomach Neoplasms; Survival Analysis | 2000 |